Eradicating HIV-1 in infected individuals will not be possible without addressing the persistence of the virus in its multiple reservoirs. In this context, the molecular characterization of HIV-1 persistence is key for the development of rationalized therapeutic interventions. HIV-1 gene expression relies on the redundant and cooperative recruitment of cellular epigenetic machineries to cis-regulatory proviral regions. Furthermore, the complex repertoire of HIV-1 repression mechanisms varies depending on the nature of the viral reservoir, although, so far, few studies have addressed the specific regulatory mechanisms of HIV-1 persistence in other reservoirs than the well-studied latently infected CD4+ T cells. Here, we present an exhaustive...
Abstract Background Current antiretroviral therapy is effective in controlling HIV-1 infection. Howe...
Abstract The persistence of HIV-1 latent reservoirs represents a major barrier to virus eradication ...
International audienceBackground: The multiplicity, heterogeneity, and dynamic nature of human immun...
Eradicating HIV-1 in infected individuals will not be possible without addressing the persistence of...
HIV-1 infections can be treated but not cured by the current antiretroviral therapy regimens. One of...
Human immunodeficiency virus 1 (HIV-1) replicates through the integration of its viral DNA into the ...
HIV-1 infection can be controlled but not cured by combination antiretroviral therapy. Indeed, the v...
With the development of effective combined anti-retroviral therapy (cART), there is significant redu...
Current antiretroviral therapies fail to cure HIV-1 (human immunodeficiency virus type 1) infection ...
Human immunodeficiency virus type 1 (HIV-1) infection is a chronic condition, where viral DNA integr...
ABSTRACT Three decades of research on human immunodeficiency virus (HIV) and AIDS reveal that the hu...
ABSTRACT Integration of the proviral DNA intermediate into the host cell genome normally represents ...
<div><p>Epigenetic modifications refer to a number of biological processes which alter the structure...
Reverse transcription of HIV-1 results in the generation of a linear cDNA that serves as the precurs...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
Abstract Background Current antiretroviral therapy is effective in controlling HIV-1 infection. Howe...
Abstract The persistence of HIV-1 latent reservoirs represents a major barrier to virus eradication ...
International audienceBackground: The multiplicity, heterogeneity, and dynamic nature of human immun...
Eradicating HIV-1 in infected individuals will not be possible without addressing the persistence of...
HIV-1 infections can be treated but not cured by the current antiretroviral therapy regimens. One of...
Human immunodeficiency virus 1 (HIV-1) replicates through the integration of its viral DNA into the ...
HIV-1 infection can be controlled but not cured by combination antiretroviral therapy. Indeed, the v...
With the development of effective combined anti-retroviral therapy (cART), there is significant redu...
Current antiretroviral therapies fail to cure HIV-1 (human immunodeficiency virus type 1) infection ...
Human immunodeficiency virus type 1 (HIV-1) infection is a chronic condition, where viral DNA integr...
ABSTRACT Three decades of research on human immunodeficiency virus (HIV) and AIDS reveal that the hu...
ABSTRACT Integration of the proviral DNA intermediate into the host cell genome normally represents ...
<div><p>Epigenetic modifications refer to a number of biological processes which alter the structure...
Reverse transcription of HIV-1 results in the generation of a linear cDNA that serves as the precurs...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
Abstract Background Current antiretroviral therapy is effective in controlling HIV-1 infection. Howe...
Abstract The persistence of HIV-1 latent reservoirs represents a major barrier to virus eradication ...
International audienceBackground: The multiplicity, heterogeneity, and dynamic nature of human immun...